Cevimeline Hydrochloride Hydrate
Tier C — Watch / tradeCevimeline Hydrochloride Hydrate
Targets：CHRM1, CHRM3
Brand：Evoxac, Saligren
Indications (approved)：Sjögren's syndrome
Regional status
Synthetic routes & intermediates4 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| CEVI-001 | 3731-38-2 | quinuclidin-3-one |
| CEVI-002 | 41353-91-7 | 4-azaspiro[bicyclo[2.2.2]octane-2,2'-oxirane] |
| CEVI-003 | 107220-26-8 | 3-(mercaptomethyl)quinuclidin-3-ol |
| Code | CAS No. | Intermediate |
|---|---|---|
| CEVI-002 | 41353-91-7 | 4-azaspiro[bicyclo[2.2.2]octane-2,2'-oxirane] |
| CEVI-004 | 173075-53-1 | quinuclidin-3-one hydrochloride |
| CEVI-005 | 1067881-02-0 | S-((3-hydroxyquinuclidin-3-yl)methyl) ethanethioate ethanethioate |
| CEVI-006 | 105-57-7 | 1,1-diethoxyethane |
| Code | CAS No. | Intermediate |
|---|---|---|
| CEVI-002 | 41353-91-7 | 4-azaspiro[bicyclo[2.2.2]octane-2,2'-oxirane] |
| CEVI-004 | 173075-53-1 | quinuclidin-3-one hydrochloride |
| CEVI-006 | 105-57-7 | 1,1-diethoxyethane |
| CEVI-007 | 1435450-13-7 | 3-(bromomethyl)quinuclidin-3-ol hydrobromide |
| Code | CAS No. | Intermediate |
|---|---|---|
| CEVI-002 | 41353-91-7 | 4-azaspiro[bicyclo[2.2.2]octane-2,2'-oxirane] |
| CEVI-004 | 173075-53-1 | quinuclidin-3-one hydrochloride |
| CEVI-008 | 78872-75-0 | S-(1-ethoxyethyl) ethanethioate |
| CEVI-009 | 1467663-46-2 | 3-(((1-ethoxyethyl)thio)methyl)quinuclidin-3-ol |
| CEVI-010 | 1467663-56-4 | 3-(((1-ethoxyethyl)thio)methyl)quinuclidin-3-ol benzoate |
| CEVI-011 | 507-09-5 | ethanethioic S-acid |
| CEVI-012 | 109-92-2 | ethoxyethene |
Frequently asked questions
What are the approved indications of Cevimeline Hydrochloride Hydrate?
Approved indications include: Sjögren's syndrome.
When does the Cevimeline Hydrochloride Hydrate patent expire?
No public expiry year is available for Cevimeline Hydrochloride Hydrate yet; this page updates once verified.
How many synthesis routes are recorded for Cevimeline Hydrochloride Hydrate?
4 synthesis routes are recorded; the shortest is 3 steps with 1.90 g total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Cevimeline Hydrochloride Hydrate intermediates?
All intermediates in Cevimeline Hydrochloride Hydrate routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Cevimeline Hydrochloride Hydrate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29